- Report
- November 2024
- 76 Pages
Asia Pacific
From €2966EUR$3,250USD£2,520GBP
- Report
- January 2025
- 90 Pages
United States
From €5429EUR$5,950USD£4,613GBP
- Report
- May 2024
- 90 Pages
United States
From €5429EUR$5,950USD£4,613GBP
- Report
- January 2025
- 140 Pages
Europe
From €3650EUR$4,000USD£3,101GBP
- Report
- August 2024
- 125 Pages
North America
From €3650EUR$4,000USD£3,101GBP
- Report
- June 2024
- 130 Pages
North America
From €3650EUR$4,000USD£3,101GBP
- Report
- March 2025
- 131 Pages
Europe
From €3148EUR$3,450USD£2,675GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3530EUR$3,869USD£3,000GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3530EUR$3,869USD£3,000GBP
- Report
- June 2024
- 140 Pages
Europe
From €3530EUR$3,869USD£3,000GBP
- Report
- June 2024
- 120 Pages
North America
From €3530EUR$3,869USD£3,000GBP
- Report
- July 2024
- 97 Pages
North America
From €2692EUR$2,950USD£2,287GBP
- Report
- July 2024
- 112 Pages
Europe
From €3148EUR$3,450USD£2,675GBP
- Report
- July 2024
- 89 Pages
Africa, Middle East
From €2692EUR$2,950USD£2,287GBP
- Report
- July 2024
- 105 Pages
Asia Pacific
From €3148EUR$3,450USD£2,675GBP
- Report
- May 2024
- 105 Pages
North America
From €2692EUR$2,950USD£2,287GBP
- Report
- May 2024
- 97 Pages
Africa, Middle East
From €2692EUR$2,950USD£2,287GBP
- Report
- May 2024
- 122 Pages
Europe
From €3148EUR$3,450USD£2,675GBP
- Report
- May 2024
- 118 Pages
Asia Pacific
From €3148EUR$3,450USD£2,675GBP
- Report
- January 2021
- 350 Pages
Global
From €4379EUR$4,799USD£3,721GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more